| A novel engineered interferon-alpha hybrid molecule increases anticancer efficacy of doxorubicin in breast cancer chemotherapy | |
| Su, Tian-Qi; Li, Si-Jie; Liu, Chun-Shui; Li, Hai-Jun; Li, Yan; Zhou, Lei; Li, Jin-Cheng; Chen, Yi-Chang; Yu, De-Hai | |
| 刊名 | INTERNATIONAL JOURNAL OF ONCOLOGY
 |
| 2017 | |
| 卷号 | 51期号:3 |
| 关键词 | phage display library interferon a doxorubicin breast cancer |
| ISSN号 | 1019-6439 |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3539723 |
| 专题 | 吉林大学白求恩第一医院 |
| 推荐引用方式 GB/T 7714 | Su, Tian-Qi,Li, Si-Jie,Liu, Chun-Shui,et al. A novel engineered interferon-alpha hybrid molecule increases anticancer efficacy of doxorubicin in breast cancer chemotherapy[J]. INTERNATIONAL JOURNAL OF ONCOLOGY,2017,51(3). |
| APA | Su, Tian-Qi.,Li, Si-Jie.,Liu, Chun-Shui.,Li, Hai-Jun.,Li, Yan.,...&Yu, De-Hai.(2017).A novel engineered interferon-alpha hybrid molecule increases anticancer efficacy of doxorubicin in breast cancer chemotherapy.INTERNATIONAL JOURNAL OF ONCOLOGY,51(3). |
| MLA | Su, Tian-Qi,et al."A novel engineered interferon-alpha hybrid molecule increases anticancer efficacy of doxorubicin in breast cancer chemotherapy".INTERNATIONAL JOURNAL OF ONCOLOGY 51.3(2017). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论